Company

Matter Bio

Biotechnology Research Key Stages in the Genomic Information Loss Continuum. 8 employees

Employees: 8
Contacts: 2
Emails: 2
Phones: 1

www.matterbio.com LinkedIn

Matter Bio Overview

Headquarters: Key Stages in the Genomic Information Loss Continuum.
Website: www.matterbio.com
Industry: Biotechnology Research
Employees: 8
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Matter Bio

Matter Bio is a longevity holding company focused on preserving genome integrity As we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss. At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome. To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.

Matter Bio Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Matter Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christopher De Solis	Principal Scientist at Matter Bio	Brooklyn, New York, United States	Email
Luis Popoca	Ms in Biology - Researcher	Bronx, New York, United States	View
Harry Robb	Principal at Lifespan Vision Ventures		View
Christopher Bradley	CEO @ Matter Bio	New York, United States	Email Phone